Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.

BACK TO LIST

Patient
Name:	Gallet, , Marthe,
DOB:	29-OCT-1950 (Age: 75)
Gender:	female
Address:	3, rue Emmanuel Goncalves 49490 Briand (France)
ID:	9444-947487-6 (ECI)

Report
Date:	24-MAR-2023

Laboratory
dr Ample, Ex Laboratoire Central Européenne Boulevard du Jardin Botanique 32 1000 Brussels (Belgium)

Requested by
CHU d'Angers Rue Larrey nan 49100 Angers (France)

Specimen
Collected:	24-MAR-2023

Chemistry

Test	24-MAR-2023	Reference Range	Unit
Glucose [Mass/volume] in Blood	68.7 L	70 - 99	mg/dL
Urea nitrogen [Mass/volume] in Blood	15.4	7 - 45	mg/dL
Creatinine [Mass/volume] in Blood	3.4 H	0.6 - 1.1	mg/dL
Calcium [Mass/volume] in Blood	9.1	8.5 - 10.4	mg/dL
Sodium [Moles/volume] in Blood	139.1	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	5.1	3.5 - 5.1	mmol/L
Chloride [Moles/volume] in Blood	110.1 H	98 - 110	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	20.1 L	22 - 29	mmol/L
Protein [Mass/volume] in Serum or Plasma	7.7	6 - 8.3	g/dL
Albumin [Mass/volume] in Serum or Plasma	4.3	3.5 - 5.5	g/dL
Globulin [Mass/volume] in Serum by calculation	2.5	2 - 3.5	g/L
Bilirubin.total [Mass/volume] in Serum or Plasma	0.3	0.3 - 1.2	mg/dL
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma	46.0	44 - 130	U/L
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma	45.3 H	7 - 33	U/L
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma	31.2	10 - 40	U/L
Cholesterol [Mass/volume] in Serum or Plasma	162.5	125 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	187.0 H	10 - 175	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	137.3 H	0 - 130	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	60.1	40 - 100	mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows elevated creatinine, suggesting impaired renal function, and mild metabolic acidosis (low CO₂, high chloride). There is also mild hypoglycemia, elevated liver enzyme (ALT), and dyslipidemia (high triglycerides, high LDL). Other parameters are within normal limits. Recommend clinical correlation for possible chronic kidney disease, metabolic disturbance, and cardiovascular risk assessment.

Conclusion and Recommendations based on this report and previous findings known to us

The patient shows elevated creatinine, suggesting impaired renal function, and mild metabolic acidosis (low CO₂, high chloride). There is also mild hypoglycemia, elevated liver enzyme (ALT), and dyslipidemia (high triglycerides, high LDL). Other parameters are within normal limits. Recommend clinical correlation for possible chronic kidney disease, metabolic disturbance, and cardiovascular risk assessment.